DAP.F Danaher Corporation

Healthcare Biotechnology Frankfurt Exchange
214.20 EUR
Close of Nov 11, 2026
137.27 215.80
Market cap
EUR 151B
P/E
40.9x
P/B
3.10x
ROE
7.8%
Dividend yield
0.68%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DAP.F undervalued?

Graham number
Price214.20
Graham value90.27
Premium137.3%

DAP.F trades 137.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Danaher Corporation fundamental analysis

No fundamental analysis for Danaher Corporation yet.

Danaher Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development…

Full company profile